Contact
Please use this form to send email to PR contact of this press release:
Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer
TO:
Please use this form to send email to PR contact of this press release:
Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer
TO: